Risk factor
Strong & resilient to price shocks
Profitability factor
Very strong margins and returns
About
Jiangsu Nhwa Pharmaceutical Co., LTD produces and sells central nervous system drugs, and cardiovascular and cerebrovascular drugs in China and internationally. The company offers drugs in the anesthesia, psychiatry, and neurological categories. It also provides APIs in the areas of central nervous system, anesthetic and sedative, and others. The company was founded in 1978 and...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, o
Target Price
The average target price of 002262.SZ is 29 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell